APG
NUVB icon

Abacus Planning Group’s Nuvation Bio NUVB Stock Holding History

Abacus Planning Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,611
Closed -$44.2K – 239
2024
Q4 		$44.2K Buy
+16,611
New +$42.8K 0.01% 223

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Abacus Planning Group's NUVB Position: Q1 2025 in Review

Abacus Planning Group sold out of Nuvation Bio (NUVB) in Q1 2025, closing a stake of 16,611 shares — an estimated $44.2K sold.

Abacus Planning Group first reported a position in NUVB in Q4 2024 and held it in 1 quarter. The position peaked at $44.2K in Q4 2024. 161 funds tracked by Wall St. Rank hold NUVB as of Q1 2025.

  • Abacus Planning Group reported no remaining Nuvation Bio position as of Q1 2025 after selling out during the quarter.
  • Abacus Planning Group sold 16,611 Nuvation Bio shares in Q1 2025, an estimated $44.2K.
  • Abacus Planning Group first reported a position in Nuvation Bio in Q4 2024 and held it in 1 quarter.
  • Abacus Planning Group's Nuvation Bio position peaked at $44.2K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2025.

Based on Abacus Planning Group's 13F filing for Q1 2025, filed 14 Apr 2025.